Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nascent Invest in connection with an investment in Pro Test Diagnostics
Mandate

Vinge has advised Nascent Invest in connection with an investment in Pro Test Diagnostics

May 08, 2020 M&A

Vinge has advised Nascent Invest in connection with their investment in Pro Test Diagnostics, which has produced a unique test kit for blood doping.

The current owner Fort Knox Förvaring is participating in the investment round and the total investment amounts to SEK 17 million.

Vinge’s team consisted of, among others, Johan Winnerblad.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026